mannin. The mechanism by which the inhibition of the phosphorylation of BAD is likely linked to the induction of lethal mitochondrial damage in TNF-intoxicated cells is discussed.
Phosphatidylinositide-3-OH kinase (PI3K)1 is a member of a signaling cascade that eventuates in the phosphorylation of the proapoptotic protein BAD (1, 2). Such growth factors as NGF and interleukin-3 are presumed to promote cell survival as a consequence of the PI3K-mediated activation of the serinethreonine kinase Akt, which in turn phosphorylates BAD (3, 4). Whereas BAD can be phosphorylated at either the Ser-112 or Ser-136 site (5), Akt phosphorylates BAD specifically at Ser-136 (phospho-BAD-136) (2, 6). BAD is capable of forming heterodimers with the antiapoptotic proteins Bcl-X L or Bcl-2 (7). Importantly, phospho-BAD-136 cannot bind either Bcl-X L or Bcl-2 (5). It is postulated that by binding to Bcl-X L and Bcl-2 BAD antagonizes their antiapoptotic activity. Upon inducing its phosphorylation, growth factors lead to the dissociation of BAD from Bcl-X L and Bcl-2 and thereby promote cell survival by allowing the unhindered action of these proteins.The PI3K inhibitor wortmannin enhanced the activation of caspase-3 that was induced by TNF or anti-Fas (8). Here we demonstrate that TNF acts like other growth factors to promote the phosphorylation of BAD at Ser-136. As a result, there is the translocation of BAD from the mitochondria to the cytosol. Moreover, the phosphorylation of BAD by TNF occurs by a PI3K-dependent pathway and is necessary to prevent the cytotoxicity of this cytokine. Inhibition of PI3K prevents both the phosphorylation of BAD and its translocation from mitochondria to the cytosol, effects that are accompanied by substantially enhanced cell killing by TNF.
EXPERIMENTAL PROCEDURESTissue Culture-HeLa cells (ATCC-CC-1, American Type Culture Collection) were maintained in 25 cm 2 polystyrene flasks (Corning Costar Corp., Oneonta, NY) with 5 ml of Dulbecco's modified Eagle's medium (DMEM) (high glucose, without pyruvate) (Life Technologies, Inc.) containing 100 units/ml penicillin, 0.1 mg/ml streptomycin, and 10% heat-inactivated fetal bovine serum, all incubated under an atmosphere of 95% air and 5% CO 2 . For transient transfections, HeLa cells were plated at one-third of confluency (3.0 ϫ 10 4 cells/cm 2 ) in 24-well plates. After overnight incubation, the cells were washed twice in phosphate-buffered saline (PBS). Transfections were performed using Lipofectamine-Plus (Life Technologies, Inc.) according to the manufacturer's instructions. Transfection efficiencies of 25-30% were routinely obtained, as assessed by -galactosidase staining. For experiments, cells were transfected with 0.5 g of pCDNA-LacZ and 5 g of either pCDNA, pCDNA3-myc-⌬p85 (referred to as pCDNA-PI3K(Ϫ)